184 related articles for article (PubMed ID: 24444519)
1. [Type 2 diabetes mellitus and obesity: should we treat the obesity or the diabetes?].
García SD; Sanz SD; Sanz AD
Med Clin (Barc); 2013 Sep; 141 Suppl 2():14-9. PubMed ID: 24444519
[TBL] [Abstract][Full Text] [Related]
2. Obesity and type 2 diabetes: Also linked in therapeutic options.
Rubio-Almanza M; Cámara-Gómez R; Merino-Torres JF
Endocrinol Diabetes Nutr (Engl Ed); 2019 Mar; 66(3):140-149. PubMed ID: 30337188
[TBL] [Abstract][Full Text] [Related]
3. How to fight obesity with antidiabetic drugs: targeting gut or kidney?
Baretić M; Troskot R
Minerva Endocrinol; 2015 Mar; 40(1):71-83. PubMed ID: 25366984
[TBL] [Abstract][Full Text] [Related]
4. Obesity in 2015: Advances in managing obesity.
Dixon JB
Nat Rev Endocrinol; 2016 Feb; 12(2):65-6. PubMed ID: 26729038
[No Abstract] [Full Text] [Related]
5. Relevance of weight in the management of patients with type 2 diabetes mellitus: towards an adipocentric approach to diabetes.
Gorgojo Martínez JJ
Med Clin (Barc); 2016 Nov; 147 Suppl 1():8-16. PubMed ID: 28760227
[TBL] [Abstract][Full Text] [Related]
6. [Impact of anti-diabetic therapy based on glucagon-like peptide-1 receptor agonists on the cardiovascular risk of patients with type 2 diabetes mellitus].
Camafort-Babkowski M
Med Clin (Barc); 2013 Aug; 141(4):167-74. PubMed ID: 23332622
[TBL] [Abstract][Full Text] [Related]
7. Impact of Current and Emerging Glucose-Lowering Drugs on Body Weight in Type 2 Diabetes.
Lau DC; Teoh H
Can J Diabetes; 2015 Dec; 39 Suppl 5():S148-54. PubMed ID: 26654858
[TBL] [Abstract][Full Text] [Related]
8. [Dapagliflozin: Beyond glycemic control in the treatment of type 2 diabetes mellitus].
Sanz-Serra P; Pedro-Botet J; Flores-Le Roux JA; Benaiges D; Chillarón JJ
Clin Investig Arterioscler; 2015; 27(4):205-11. PubMed ID: 25648671
[TBL] [Abstract][Full Text] [Related]
9. Current and Emerging Pharmacotherapies for Weight Management in Prediabetes and Diabetes.
Lau DC; Teoh H
Can J Diabetes; 2015 Dec; 39 Suppl 5():S134-41. PubMed ID: 26654857
[TBL] [Abstract][Full Text] [Related]
10. [Effects of GLP-1 receptor agonists on carbohydrate metabolism control].
Fernández-García JC; Colomo N; Tinahones FJ
Med Clin (Barc); 2014; 143 Suppl 2():18-22. PubMed ID: 25326839
[TBL] [Abstract][Full Text] [Related]
11. Positioning of sodium-glucose cotransporter-2 inhibitors in national and international guidelines.
Morillas C
Med Clin (Barc); 2016 Nov; 147 Suppl 1():49-53. PubMed ID: 28760226
[TBL] [Abstract][Full Text] [Related]
12. Use of sodium-glucose cotransporter type 2 inhibitors in older adults with type 2 diabetes mellitus.
Mikhail N
South Med J; 2015 Feb; 108(2):91-6. PubMed ID: 25688893
[TBL] [Abstract][Full Text] [Related]
13. Managing highly insulin-resistant diabetes mellitus: weight loss approaches and medical management.
Brown A; Desai M; Taneja D; Tannock LR
Postgrad Med; 2010 Jan; 122(1):163-71. PubMed ID: 20107300
[TBL] [Abstract][Full Text] [Related]
14. [Sodium-glucose co-transporter-2 inhibitors: from the bark of apple trees and familial renal glycosuria to the treatment of type 2 diabetes mellitus].
Mauricio D
Med Clin (Barc); 2013 Sep; 141 Suppl 2():31-5. PubMed ID: 24444522
[TBL] [Abstract][Full Text] [Related]
15. [Type 2 diabetes mellitus: new treatments].
Ascaso JF
Med Clin (Barc); 2014 Aug; 143(3):117-23. PubMed ID: 23937815
[TBL] [Abstract][Full Text] [Related]
16. Effects of antidiabetic drugs on the incidence of macrovascular complications and mortality in type 2 diabetes mellitus: a new perspective on sodium-glucose co-transporter 2 inhibitors.
Rahelić D; Javor E; Lucijanić T; Skelin M
Ann Med; 2017 Feb; 49(1):51-62. PubMed ID: 27535028
[TBL] [Abstract][Full Text] [Related]
17. Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action.
Grams J; Garvey WT
Curr Obes Rep; 2015 Jun; 4(2):287-302. PubMed ID: 26627223
[TBL] [Abstract][Full Text] [Related]
18. Dapagliflozin promotes beta cell regeneration by inducing pancreatic endocrine cell phenotype conversion in type 2 diabetic mice.
Wei R; Cui X; Feng J; Gu L; Lang S; Wei T; Yang J; Liu J; Le Y; Wang H; Yang K; Hong T
Metabolism; 2020 Oct; 111():154324. PubMed ID: 32712220
[TBL] [Abstract][Full Text] [Related]
19. Bariatric surgery may reduce the risk of Alzheimer's diseases through GLP-1 mediated neuroprotective effects.
Keshava HB; Mowla A; Heinberg LJ; Schauer PR; Brethauer SA; Aminian A
Med Hypotheses; 2017 Jul; 104():4-9. PubMed ID: 28673587
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial.
Davies MJ; Bergenstal R; Bode B; Kushner RF; Lewin A; Skjøth TV; Andreasen AH; Jensen CB; DeFronzo RA;
JAMA; 2015 Aug; 314(7):687-99. PubMed ID: 26284720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
